-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Coeptis Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2019 to Q3 2022.
- Coeptis Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$5.65M, a 5.01% increase year-over-year.
- Coeptis Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$37.5M, a 238% decline year-over-year.
- Coeptis Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$13.4M, a 46.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)